# Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection

> **NCT02852564** · PHASE1 · COMPLETED · sponsor: **Eugene Lee, MD** · enrollment: 12 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Ethacrynic Acid

## Key facts

- **NCT ID:** NCT02852564
- **Lead sponsor:** Eugene Lee, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02852564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02852564, "Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT02852564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*